Jane (Jie) Liang brings many years of industry experience, of which the last 15 in the field of medical devices, to the Qserve Group, an international medical device regulatory consultancy with experts in regulatory compliance, clinical evaluation, quality assurance, global registration, auditing and training for international medical device manufacturers. Jane will be part of Qserve’s local Chinese team and from there strengthen the global Clinical Evaluation team, headed up by Dr. Anna Pietersma, in the position of Senior Consultant.
Due to changes in regulations in the European medical device directives and the focus of the Qserve Group on high risk and complicated medical devices, clinical evaluation is growing in importance. Also clinical studies in China deserve a specialist approach and local experience and regulatory knowledge to be able to support medical device manufacturers entering the Chinese market with their devices.
Willibrord Driessen, Founder of Qserve Group and CEO of the Qserve China, is pleased to have a medical doctor in the local Chinese team now. “Qserve China’s local regulatory team could already offer a high level of expertise, but with the current and expected global pressure on clinical evaluation it was necessary to add a Chinese clinical expert to the global clinical evaluation team. With this Qserve broadens her service level even more and confirms her position as global partner for all medical device regulatory.”
Jane’s last position was Director of Regulatory Affairs and Clinical Affairs at Carl Zeiss Shanghai Co. Ltd for imported products and global and domestic registrations. This experience combined with experience as a physican in Beijing You Dian Hospital and experience with both medical devices and pharmaceutical products like cardiovascular and respiratory drugs, makes her a valuable addition to Qserve’s team.
For more information, please see her profile.